Cryoport Supports ArunA Biomedical’s Cryogenic Shipments of Stem Cell Kits

June 3, 2015

Lake Forest, CA, June 3, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that the Company is supporting ArunA Biomedical’s (“ArunA”) cryogenic shipments of stem cell kits.

Read More

Tags: Cold Chain Logistics, ArunA, stem cell kits